HHL posted strong earnings for 4Q FY24 with an EPS of LKR 2.64 (+49% YoY) largely supported by a ~49% reduction in finance costs. Group topline saw a marginal decline of 2.4% YoY to LKR 31.4bn as degrowth in consumer brands offset the growth in other segments. Change of seasonality impacted the contribution from Atlas which led to this decline. Albeit Healthcare was the top contributor to HHL’s topline, Consumer accounted for the higher share in EBIT and PAT.